Dentsply Sirona (NASDAQ:XRAY) – Jefferies Group upped their Q2 2018 earnings per share estimates for shares of Dentsply Sirona in a research note issued to investors on Monday, April 16th. Jefferies Group analyst B. Couillard now expects that the medical instruments supplier will earn $0.65 per share for the quarter, up from their prior estimate of $0.64. Jefferies Group has a “Buy” rating on the stock.
Dentsply Sirona (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.01. The firm had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. Dentsply Sirona had a negative net margin of 39.39% and a positive return on equity of 8.35%. Dentsply Sirona’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.67 earnings per share.
Several other research firms have also weighed in on XRAY. Credit Suisse Group dropped their price objective on shares of Dentsply Sirona from $73.00 to $69.00 and set an “outperform” rating on the stock in a research note on Friday, March 2nd. BidaskClub lowered shares of Dentsply Sirona from a “sell” rating to a “strong sell” rating in a research note on Wednesday, February 28th. JPMorgan Chase dropped their price objective on shares of Dentsply Sirona from $75.00 to $70.00 and set an “overweight” rating on the stock in a research note on Monday, March 5th. HC Wainwright set a $63.00 price objective on shares of Dentsply Sirona and gave the stock a “hold” rating in a research note on Monday, March 5th. Finally, Barrington Research restated an “outperform” rating and issued a $70.00 price target (down previously from $73.00) on shares of Dentsply Sirona in a research note on Monday, March 5th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $67.36.
XRAY opened at $50.62 on Wednesday. The stock has a market cap of $11,411.61, a P/E ratio of 19.03, a price-to-earnings-growth ratio of 2.21 and a beta of 1.26. Dentsply Sirona has a fifty-two week low of $48.25 and a fifty-two week high of $68.98. The company has a current ratio of 2.10, a quick ratio of 1.45 and a debt-to-equity ratio of 0.24.
Large investors have recently made changes to their positions in the business. Victory Capital Management Inc. increased its stake in shares of Dentsply Sirona by 22,502.5% in the fourth quarter. Victory Capital Management Inc. now owns 855,955 shares of the medical instruments supplier’s stock valued at $56,348,000 after purchasing an additional 852,168 shares during the period. LPL Financial LLC boosted its holdings in shares of Dentsply Sirona by 2.5% in the fourth quarter. LPL Financial LLC now owns 42,283 shares of the medical instruments supplier’s stock valued at $2,783,000 after acquiring an additional 1,024 shares in the last quarter. Bank of Montreal Can boosted its holdings in shares of Dentsply Sirona by 6.1% in the fourth quarter. Bank of Montreal Can now owns 211,583 shares of the medical instruments supplier’s stock valued at $13,929,000 after acquiring an additional 12,211 shares in the last quarter. Teachers Advisors LLC boosted its holdings in shares of Dentsply Sirona by 2.4% in the fourth quarter. Teachers Advisors LLC now owns 355,233 shares of the medical instruments supplier’s stock valued at $23,385,000 after acquiring an additional 8,227 shares in the last quarter. Finally, Oakbrook Investments LLC bought a new position in shares of Dentsply Sirona in the fourth quarter valued at approximately $589,000. Institutional investors own 97.79% of the company’s stock.
The company also recently declared a quarterly dividend, which was paid on Friday, April 13th. Shareholders of record on Thursday, March 29th were paid a $0.0875 dividend. The ex-dividend date of this dividend was Wednesday, March 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.69%. Dentsply Sirona’s payout ratio is currently 13.16%.
TRADEMARK VIOLATION NOTICE: “Jefferies Group Analysts Lift Earnings Estimates for Dentsply Sirona (XRAY)” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/19/jefferies-group-analysts-lift-earnings-estimates-for-dentsply-sirona-xray.html.
Dentsply Sirona Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Receive News & Ratings for Dentsply Sirona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply Sirona and related companies with MarketBeat.com's FREE daily email newsletter.